Medical Devices Today

Domain Surgical Inc.

Article preview from Start-Up - October, 2012

A surgeon’s wish list for a dissection tool would likely include these four features: a superficial tissue hemostatic effect without deep tissue injury, frictionless cutting without distortion or sticking, on-demand rapid onset and offset of effect, and easy cleaning to maintain the pace of surgery. Domain Surgical Inc. thinks its FMwand Ferromagnetic Surgical System meets these needs. “The device is based on the principal of ferromagnetic induction, whereby radiofrequency energy is passed around a loop of wire to produce heat that is capable of cutting and coagulating tissue.

Device/Diagnostics Quarterly Deal Statistics, Q2 2012

Article preview from IN VIVO - October, 2012 

Medical device company financing brought in $977 million, a decrease over Q1’s $1.1 billion. Device acquisition activity was up to $4.6 billion, yet only one deal surpassed the billion-dollar mark. With late-stage financing again leading, diagnostics funding together brought in $336 million, an 11% increase over Q1. For the first time since Q1 2011, the diagnostics M&A dollar total moved up instead of down, with $7 billion in acquisitions and five of the seven transactions topping $100 million.

Trends In Colorectal Cancer Screening – The Impact Of Health Care Reform: An Interview With Brian Jacobson, MD

Article preview from Medtech Insight - September, 2012

Medtech Insight recently spoke with Brian Jacobson, MD, associate professor of medicine at Boston University School of Medicine, and the chair of the American Society for Gastrointestinal Endoscopy’s Health and Public Policy Committee, about trends in colorectal cancer screening and the potential impact that health care reform will have on the colonoscopy market.

Industry, Hospital Groups Debate Implementation Deadlines For UDI Rule

Article preview from "The Gray Sheet" - November 12, 2012

Device industry groups are calling for FDA to extend the timeframes for requiring unique device identifiers on all products to allow firms more time to prepare, while hospitals are urging a shorter implementation timetable to enable earlier use of the system to track devices and recalls.

Healionics Spins Out Ophthalmic Device Company In Europe

Article preview from Start-Up - October, 2012

Companies offering broadly applicable biomaterials platforms often have an identify problem and with that, a funding problem. Seattle-based Healionics Corp. is solving that problem by creating clinically focused spin-outs that just happen to be in Europe where they can capture non-dilutive funding from regional governments. The company’s first spin-out, iSTAR Medical SA, is working on ophthalmic devices, specifically a suprachoroidal drainage shunt for glaucoma. In September, iSTAR was awarded a €3.6 million ($4.7 million) grant from Belgium’s Région Wallonne government.

Could Medtronic’s Kanghui Purchase Set Course For US Entry?

Article preview from IN VIVO - October, 2012 

Last month Medtronic agreed to pay close to $800 million for Chinese orthopedics implant maker China Kanghui Holdings. To be sure, the purchase of Kanghui secures Medtronic’s footing in China, one of the fastest growing health care economies in the world. In addition, it likely will help Medtronic close in on its goal of bringing in 20% of its revenue from emerging markets.

Neurointerventional Device Update: The Burgeoning Stroke Toolbox

Article preview from Medtech Insight - September, 2012
 

The treatment of acute ischemic stroke and brain aneurysms is rapidly evolving. New transcatheter devices and adjuvant imaging promising to improve outcomes and reduce the burden of neurovascular disease. However, to really spur this market, long-term, large-scale clinical trials are needed.

Device Industry Campaign Contributions Favor Republicans This Election

Article preview from "The Gray Sheet" - November 5, 2012

Direct contributions from individuals or company political action committees to candidates from the pure-play device industry totaled $4.7 million to Republicans and $2.9 million to Democrats, as of Oct. 31. This clear edge toward Republicans is a shift from prior election cycles.